Professor Viroj Wiwanitkit is a medical professor and Asian Scholar. He is presently a visiting University Professor, Hainan Medical University, China. He has more than 950 international journal publications and 150 international textbook publications. He is editor in chief and editorial board of more than 40 journals. He has ever been invited to be keynote speakers of many international conferences. He is the Thai scientists with the most number of publications. He is a guest lecturer of many universities.
Christopher Koroneos is a chemical engineer. He did all his studies at the Department of Chemical Engineering of Columbia University in New York, USA, where he later was a professor and continues to be associated with the Earth Engineering Center as a Research Associate. Now he is Associate Professor having the chair of Renewable Energy and Energy Management at the Department of Mechanical Engineering of the University of Western Macedonia in Greece. He is also at the Unit of Environmental Science and Technology of the Department of Chemical Engineering at the National Technical University of Athens. He is teaching at the Interdisciplinary Programme of Post Graduate Studies ‘‘Environment & Development’’ of the National Technical University of Athens. His research interests are in Renewable Energy, Exergy Analysis, Life Cycle Assessment and Sustainable Development. He has more than 90 publications in Scientific Journals and more than 220 publications in proceedings of International conferences. He is in the editorial committee of 35 scientific journals, and he has participated in 37 national and international research projects.
Ajay Nair has completed his PhD from University of Otago, New Zealand and postdoctoral studies from Oklahoma Medical Research Foundation, USA. He has published in several reputed peer-reviewed journals and has been serving as an editorial board member of repute.
Professor Akbar Nikkhah holds BSc in Animal Sciences (University of Zanjan, Iran,1999), MSc in Animal Nutrition (Isfahan University of Technology, Iran, 2001), PHD in Dairy Nutritional Physiology (University of Manitoba, Canada, 2007) and PostDoctorate in Nutritional Genomics and Management (University of Illinois, US, 2008). Dr. Nikkhah has received numerous national and international awards & honors and has authored more than 400 influential global scientific publications namely articles, editorials, books, and book chapters. Professor Nikkhah significantly influences upon and changes lives of countless people, mentees, mentors, groups, industries, universities, schools, and global institutions in accomplishing resourceful economy and quality life. He speaks in a variety of national and international conferences and meetings and serves more than 500 national and international journals, conferences, and publishers as chief science advisor, editor and evaluator. He serves the global community as Chief Highly Distinguished Professor and Mentor (University of Zanjan, Iran) and Frontier Highly Distinguished Peace Leader with diversified programs in multidisciplinary and interdisciplinary science and technology research and education.
Afaf El-Ansary, female, biochemist, graduated from biochemistry department, Ain Shams University, Egypt in 1974. She worked in the National Research Centre, Egypt from 1976-2000, During 2001-2016, she worked as professor, Biochemistry Department, Science College, King Saud University, KSA. Since 2016- till now, she joined the Central laboratory as senior scientist to supervise the Biochemistry, Proteomic and biomarkers units. She has published more than 45 papers related to metabolic integration between schistosome parasite and molluscan hosts. She recorded a patent on the" use of sublethal concentration of solanum nigrum plant for the control of schistosomiasis". She was recognized by the Marquis Who's Who in science and engineering, Eight's edition, 2005-2006. She is member in number of national and international societies and she is recorded as reviewer in many international journals. In recent years she focused on the screening of biochemical markers related to autism and she got another 56 published papers in high impact factor Journals related to this research interest. She is member in the European Society of Predictive, Preventive and Personalized Medicine Society (Moscow).
Professor Abdulghani Mohamad Alsamarai completed his undergraduate studies at College of Medicine, Basrah University in 1977 and received his MGUM degree in Genitourinary Medicine  and Ph D in Clinical Virology  from Sheffield University, UK. He assumed a faculty position in College of Medicine, Basrah University in 1986. Now he completed 31 years working as consultant in Allergy, Dermatology, Infectious Diseases and Medical Education in Basrah and Tikrit Universities. At Universities [Basrah, Tikrit, Lahaye international] he has served as a Teaching Assistant, Lecturer, Assistant Professor and full Professor in 1994. He appointed as Dean of Tikrit University College of Medicine from 2000 to 2003, Chairman of Tikrit University Promotion Committee and a Dean of College of Applied Medical Sciences, Lahaye International University. In addition, he is acting as Director of Joint Diploma for Health Profession Education Programme and WHO senior consultant. Prof Alsamarai awarded grade A senior scientist because of his contribution in National Drug Formulation Programme and Community Health Promotion Research Programme. One of his responsibilities was to set up a postgraduate studies in Basrah University Medical College, acting as chairman of Examination Committee and Department of Microbiology, Basrah Medical College. In 1991 he join Tikrit University College of Medicine [TUCOM] as assistant professor and work to set up the Departments of Research in the university, and Medical Education Department, Curricula for Dermatology, Medicine, Surgery and Gynecology in TUCOM. Furthermore, once he joined TUCOM he is acting as chairman for Research Committee, Promotion Committee, and 6th year Learning Committee. Since 1977 his research focused on several issues including fungal, viral, bacterial, allergic and dermatologic diseases. Recently, he focuses on the role of oxidants / antioxidants, non invasive biomarkers of allergic diseases. He teaches several courses in undergraduate and postgraduate studies in Basrah Medical College and TUCOM. These courses include: Fungal diseases, Clinical Virology, Sexually Transmitted Diseases, Medical Education, Health Profession Education, Dermatology, Infectious Diseases, Allergic Diseases and Research Methods. He acts as Director of M Sc and Ph D in Medical Microbiology, High Diploma in Allergy and Immunological Diseases, and Joint Diploma in Health Profession Education with Suez Canal University, Faculty of Medicine. Professor Alsamarai has received a good contribution from National and International agencies to support his research on drug formulation, searching for new drugs, bioavailability of drugs, Plant products research, National Programme for Prevention a nd Control of Disease, and Community Health Promotion Research.
Dr. Mosaad Attia Abdel-Wahhab is a professor of Toxicology and food safety at National Research Center. He has completed his PhD from Ain Shams University, Cairo, Egypt and Texas A & M University, Texas, USA. He is a visiting Professor at several International Universities and published more than 220 research articles in the areas of Foodomics, Proteomics, food safety, nanotechnology and biotechnology in the high impact factor international peer review Journals. He supervised more than 55 MSc and PhD thesis and conducted 18 International research projects. He participated in 58 international conferences as invited or keynote speaker. He is co-editor for 9 International Journals and a member in several International societies. He is the president of the Egyptian Society of Science and Halal Research.
Mohamed Eddouks is Professor at Moulay Ismail University, Faculty of Sciences and Techniques Errachidia, Morocco. He is a researcher in Physiology and Pharmacology with a Master Degree in Metabolic and Molecular Endocrinology from University of Paris vi, a specialized certificate in Endocrine Pharmacology from University of Paris vii and PhD degrees in Physiology and Pharmacology from University of Liege, Belgium and Sidi Mohammed Ben Abdellah University, Fez, Morocco. After his post-doctoral fellowship at Department of Physiology, Faculty of Medicine of Montreal, Canada, he is working for the last 16 years on medicinal plants. His work on antidiabetic and antihypertensive plants is well recognized globally. His research focuses on ethnobiological as well as pharmacological issues in the use of Moroccan medicinal plants for the treatment of diabetes mellitus, obesity and hypertension. His contribution to this field includes four international books and more than 80 peer-reviewed articles and book chapters of international repute. He served as Guest Editor and Member of Editorial Board of several international journals. He has been honored with the first Prize of Scientific Research in 2008 by the Moroccan Association of Research and Development and the first Prize of the Federation of Arab Scientific Councils in 2016. He has been the founding Dean of Polydisciplinary Faculty of Errachidia from 2008 to 2012.
Amer A. Taqa: Professor at Dental Basic Science, College dentistry, Mosul University, Iraq. Have PhD degree in Dental chemistry. He has published more 100 researches papers in national and international academic journals and authored 22 books. His research interests include dental chemistry, medical chemistry, and inorganic chemistry. He is editorial member in more than 140 international journals. He Nominated as a member of the organizing committees for a number of international and local conferences. E-mail: email@example.com Publons: https://publons.com/a/331136 ORCID: http://orcid.org/0000-0002-3104-0078 https://www.linkedin.com/mynetwork/ https://www.researchgate.net/ http://www.researcherid.com/Workspace.action
Dr. Anjana Rani is Ph.D. from Banaras Hindu University, Department of Biochemistry. She has been designated as DST-WOS-A. She has published 6 papers in reputed journals and served as Principle investigator of a project funded by Department of Science and Technology. The major area of her research covers stress physiology and proteomics in plants as well as the understanding molecular mechanism of the genes involved in boron toxicity tolerance.
Dr. Cho was the Professor of Radiological Science as well as Professor of Psychiatry and Human Behavior at University of California at Irvine. From 2005, Prof. Cho served as University Professor and Director of the Neuroscience Research Institute, Gachon University of Medicine & Science, Incheon, till he joined as a Distinguished Research Fellow at the Adavanced Institute of Convergence Technology (AICT), Seoul National University, Seoul, Korea. Since 2017, Professor Cho is concurrently serving as a director of Neuroscience Research Institute, Suwon University, Suwon, Korea. Prof. Cho was the one who pioneered world’s first "Ring PET", the molecular imaging device, in 1975. Professor Cho has also been pioneer in the field of MRI. In 2005, 7.0T MRI coupling with super resolution PET (HRRT) ,the world’s first PET-MRI fusion system was developed at GachonUniversity, Inchon, Korea. Among the many honors and awards, Professor Cho was elected as a member of US National Academy of Science, Institute of Medicine in 1997 (Now US National Academy of Medicine).
Yichuan Zhao has completed his PhD from the Florida State University, USA. He is the full professor of Statistics, Georgia State University. He has published 90 papers in statistics and computer science and has been serving as an editorial board member of many journals.
Prof. Wang is a Professor at Xi’an Jiaotong-Liverpool University, a Chinese-British joint higher educational venture in China. He earned his PhD in Bio-Organic Chemistry from Washington University in St. Louis, USA, and was an NIH-NRSA postdoctoral fellow studying mechanisms of DNA repair in mammalian system. He joined the faculty of Indiana University School of Medicine in 2001 and served as a Proteomics Core director for 16 years. His research centers around biomarkers and drug target discovery, and deciphering the protein interaction networks in complex human diseases with the use of high throughput omics technologies and bioinformatics.
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1985 through 1987, worked at Inst of Med Enzymology, USSR Academy of Medical Sciences. From 1987 through 1989, was a senior Researcher, Koltzov Inst of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, was being a Head of the Lab of Clinical Immunology and Immunobiotechnology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004, was being a Chairman of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. In 1993-1996, was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. Dr Suchkov is a Co-Supervisor over the Russian-American Agreement on scientific and clinical collaboration in the field of ocular immunology between Russian Academy of Sciences and National Institutes of Health (NIH); in 1991-1995 – a member of The Reciprocal Exchange Fellowship Program between Russian Immunological Society and British Society for Immunology. Dr Suchkov is a member of the Editorial Boards of many international journals including EPMA Journal (Springer, Brussels) and “Personalized Medicine Universe” (Elsevier, Japan). Dr Sergey Suchkov, MD, PhD Director, Center for Personalized Medicine and Professor, Department of Pathology, Sechenov University, Chair, Department for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Professor, Dept for Immunology, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia Member, New York Academy of Sciences, NY, USA Secretary General, UCC (United Cultural Convention), Cambridge, UK Member, EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brus-sels, EU; Member, ISPM (International Society for Personalized Medicine), Tokyo, Japan; Member, PMC (Personalized Medicine Coalition), Washington, USA; Member, American Chemical Society (ACS), USA; Member, American Heart Association (AHA), USA; Secretary General, UCC (United Cultural Convention), Cambridge, UK
Vittorio Bellotti is a medically qualified scientist who has worked on protein misfolding disorders both in the UK and Italy for over 20 years. His seminal demonstration that the amyloidogenic variants of lysozyme, discovered in the laboratory of Professor Sir Mark B. Pepys at the Royal Postgraduate Medical School, Hammersmith Hospital in 1993, were less stable than the wild type molecule provided the basis for a now generally accepted theory explaining the mechanism of amyloid conversion of globular proteins. In 1995 he established an independent group at the University of Pavia carrying out pioneering work on β2-microglobulin fibrillogenesis causing dialysis-related amyloidosis. He made a series of key discoveries including the characterization of the pathogenic role of the truncated form of β2-microglobulin, ΔN6β2-microglobulin, ubiquitous in osteoarticular amyloid deposits, the demonstration that collagen and heparin could have a prominent role in amyloid fibril formation in vivo and the identification of a range of inhibitors of β2-microglobulin fibrillogenesis including nanobodies and doxycycline. He has also continued his association with the Pepys laboratory and was central to the identification of the transthyretin superstabiliser, mds84, and the subsequent collaboration with GlaxoSmithKline to develop this material as a potential transthyretin amyloidosis therapy. He joined UCL in October 2011 with MRC Strategic Award, where he established a new group in the Centre for Amyloidosis and Acute Phase Proteins. At UCL he has continued his research into the molecular mechanisms of amyloidogenesis as exemplified in two recent studies, which both arose out of his work following the identification of new pathogenic variants of amyloidogenic proteins. He identified the biochemical mechanisms underlying the pathogenicity of the first (and only) amyloidogenic variant of β2-microglobulin, D76N. This led to the seminal observation that forces generated under physiological conditions by agitation of fluids in the presence of hydrophobic-hydrophilic interfaces are sufficient to cause protein fibrillogenesis, and may represent a common mechanism of amyloidogenesis by globular proteins in vivo. He identified a previously unrecognized step in the development of transthyretin amyloidosis by demonstrating that stress-mediated proteolysis is a pivotal step in the protein fibrillogenesis pathway. His research strategy is inspired by the challenging objective of relating in vitro experimental conditions to the pathophysiological environment. He believes that the most efficient way to identify the underlying causes of complex diseases such as systemic amyloidosis is by collaboration between groups with complementary expertise and ideas. He has kept a close connection with his group in Pavia and continued to work with a network of longstanding collaborators in Italy including Professors Esposito (Udine), Relini (Genoa), Bolognesi (Milan), Cecconi (Modena). At UCL he has developed a number of collaborations. These include work on alpha-synuclein (Professor Schapira), apolipoprotein C-III (Professor Talmud), structural insights into amyloidogenic proteins (Professor Christodoulou) and the generation of bio-compatible devices to study fibrillogenesis of human globular proteins (Professor Pinzani). Other external collaborations include the use of native mass spectrometry for protein structure analysis (Professor Robinson, Oxford) and work on new amyloidogenic variants of β2-microglobulin and apolipoprotein C-III (Professor Valleix, Paris).
Magnus S Magnusson completed his PhD in 1983 from University of Copenhagen. He is a Research Professor and creator of the T-system model and algorithms implemented in Theme™. He focuses on real-time organization of behavior, co-directed a two-year DNA analysis project, and published numerous papers. He gave invited talks at numerous conferences (including AIMS, IFNA, Neurotalk, Proteomics) and universities in Europe, USA and Japan. He is Deputy Director between 1983 and 1988, Anthropology Laboratory, Museum of Natural History, Paris. He is a repeated invited Professor at Universities of Paris (V, VIII, XIII). Since 1991, he is Founder and Director of the Human Behavior Laboratory, University of Iceland. Since 1995, he focused on collaboration between 24 universities based on “Magnusson’s Analytical Model” initiated at the Sorbonne, Paris.
He was the director of the Alexandria University Hospital Labs for 3 years and at the same time the director of the Alexandria Medical Research Labs . He was the Head of Department of Clinical and Chemical Pathology since 2014 till 2017.He has published more than 35 publications in reputed international journals. Has been serving as one of the judgment committee of the projects introduced to Royan 6th international research award. He is a member of Board of Directors of the Egyptian Society of Laboratory Medicine.In 1993 he was honoured by Ministry of scientific reseaech and got the prize from Egypt Country for persons. In 2002 he got The 1st prize in accepted talks In the 18th International Congress of Clinical Chemistry and Laboratory Medicine IFCC , Kyoto , Japan.In 2009 he was selected as The ideal doctor by the syndicate of doctors of Egypt.
He is working as Regents Distinguished Professor, Diagnostic Medicine Pathobiology, In his words he says The overall goal of my research is to investigate emerging diseases of livestock focusing mainly on viral and prion diseases. We work on influenza viruses, especially swine and avian influenza viruses. We try to understand molecular mechanisms of how influenza viruses are transmitted between animal species and which viral genes are critical for this process. In addition, we try to develop broader and more efficient vaccines. Reverse genetics technology is one of the techniques used in this line of research. Rift Valley Fever virus is another zoonotic pathogen we are working on. Our goal is the development of novel vaccines and diagnostic tools. The prion research conducted is based on prion protein-deficient knock-out cattle, which we previously generated. Here we try to produce knock-in cattle expressing mutated bovine prion proteins using homologous recombination. Recently, I became the director of the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), funded by the Department of Homeland Security
Dr.S.K.Sood is working as a scientists in the division of Animal biochemistry.In depth knowledge in Biochemistryand Molecular biology, Genetics, Microbiology, Physiology, Immunology, Chemistry.Extensive working experience in various bio-techniques in Bacterial, Cell and Embryo Culture, rDNA, Protein Purification and characterization, etc.In depth practical knowledge of BLAST/FASTA, MSA, phylogenetic analysis and Protein Modelling. Received Appreciation letter from The Director of NDRI for developing web site of the institute. Received appreciation letter from The Director and JD (R) for excellent research project presentation and effective communication.
Victor Tsetlin has received his PhD in 1973, from 1996 he is a Professor and from 2006 he is the corresponding Member of the Russian Academy of Sciences, Head of the Department. He was a Visiting Scientist at Imperial College, London in 1985 and Visiting Professor at Free University of Berlin in 1993-1995. He was a Member of ESN Council in 1999-2009, Member of the Advisory Board of the EJB-FEBS Journal in 2000-2011 and from 2013 Member of the Advisory Board at the Biochemical Journal. He is the author of over 250 publications in many journals among them Journal of Neurochemistry, Journal of Biologicalk Chemistry, Proceedings of National Academy of Sciences, USA, Nature Strutural and Molecular Biology, Trends in Pharmacological Science.
Dr. Pelech is a full professor in the Division of Neurology in the Department of Medicine at the University of British Columbia (UBC), where he has been on faculty since 1988. He is also concurrently the principal founder, president and chief scientific officer of Kinexus Bioinformatics Corporation.He was the principal founder of Kinetek Pharmaceuticals, Inc. and served as its president for six years and was one of the founding scientists of the Biomedical Research Center at UBC. Prior to his academic and industrial experience, he spent five years in post-doctoral training with Sir Philip Cohen at the University of Dundee in Scotland and Nobel laureate Dr. Edwin Krebs at the University of Washington in Seattle. Dr. Pelech received his B.Sc. (1979; Honours) and Ph.D. (1982) degrees in Biochemistry from UBC.Dr. Pelech has authored over 220 scientific publications in peer-reviewed journals and book chapters about signal transduction and is one of the discoverers of the MAP kinase family of cell signalling proteins. His accolades include the 1993 Martin F. Hoffman Award for Research at UBC, and the 1993 Merck Frosst Canada Prize from the Canadian Society of Biochemistry and Molecular Biology. He is the 2001 Distinguished Lecturer for the Faculty of Medicine at UBC for the basic sciences. He has served on grant review panels for the US National Institutes of Health, the Canadian Institutes for Health Research, the National Research Council of Canada, the Michael Smith Health Research Foundation, Genome Alberta, Genome Prairie, the Canadian National Cancer Institute, the Canadian Heart and Stroke Foundation and the American Heart Association, and has acted as an external reviewer for 22 other agencies including the U.S. National Science Foundation and the Israel Science Foundation. He has also been an external reviewer for over 28 scientific journals.
Celso Cunha has a PhD in Biology from University of Lisbon in 1992. He is an Associate Professor with Habilitation in the Institute of Hygiene and Tropical Medicine of Nova University, in Lisbon, Portugal. As leader of a small research group, his main research interests are focused on the biology and pathology machanisms associated with Hepatitis Delta virus and Hepatitis B virus infections. He served as reviewer for several publications and is a member of the evaluation panel of different international funding agencies.
Panos M. Pardalos serves as distinguished professor of industrial and systems engineering at the University of Florida. Additionally, he is the Paul and Heidi Brown Preeminent Professor of industrial and systems engineering. He is also an affiliated faculty member of the computer and information science Department, the Hellenic Studies Center, and the biomedical engineering program. He is also the director of the Center for Applied Optimization. Pardalos is a world leading expert in global and combinatorial optimization. His recent research interests include network design problems, optimization in telecommunications, e-commerce, data mining, biomedical applications, and massive computing.
Boris Zaslavsky received his Ph.D. degree in 1972 and D.Sc. degree in 1986 from the USSR Academy of Sciences. He moved to USA in 1991 where he worked at Argonne National Laboratory and in 1997 he was a cofounder of Analiza, Inc. where he served as Vice-President. In 2013 he cofounded Cleveland Diagnostics where he serves as Chief Scientific Officer. He is the author of one monograph, over 150 publications in various peer-reviewed journals, and over 10 US patents. He presented his work at multiple international conferences and serves as a chair and member of organizing committee of numerous proteomics and bioanalytical conferences.
Kristi Neufeld is the professor of cancer researh fro university Kansas,USA.Now underlying project is Role of APC tumor suppressor protein in normal colon and in cancer.Our long-range goal is to reveal the underlying mechanisms for growth control of normal intestinal tissue, explaining how disruption of this normal state leads to tumor formation.
He worked as post doctoral felow,Sessional Assistant Professor, Senior Laboratory Instructor from 1973 - 1984 from university of victoria , canada. The research of my group has concentrated on the use of Artificial Intelligence to solve scientific problems.Work is currently underway on an environmental project in which both Agent-based Modelling, a further Artificial Intelligence technique, and Genetic Algorithms are being used to map the origin of oil spills at sea.